Blockchain Registration Transaction Record

TransCode Therapeutics Names Dr. Phillip D. Zamore to Scientific Advisory Board

TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board. The addition enhances the company's focus on RNA-targeted cancer therapy programs, marking a strategic development in the fight against metastatic disease.

TransCode Therapeutics Names Dr. Phillip D. Zamore to Scientific Advisory Board

This news highlights the strategic addition of a renowned expert in RNA research to TransCode's team, signaling a significant step forward in the development of RNA-targeted cancer therapies. Dr. Zamore's appointment underscores the company's commitment to advancing innovative treatments for metastatic disease.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0xe774902fb180caf175e569c0239a4bb52b8ef218f018b0b309957d01cac9daad
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprinturgeSLmC-d37367a7cbe5a13a564518bcb8893c1f